HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sachiko Chikahisa Selected Research
Sachiko Chikahisa Research Topics
Disease
4
Sleep Deprivation
04/2014 - 04/2006
1
Pain (Aches)
10/2022
1
Hyperalgesia
10/2022
1
Insulin Resistance
10/2021
1
Restless Legs Syndrome (Restless Legs)
11/2019
1
Chronic Kidney Failure (Chronic Renal Failure)
11/2019
1
Glucose Intolerance
10/2017
1
Narcolepsy
11/2016
1
Alzheimer Disease (Alzheimer's Disease)
09/2013
1
Dementia (Dementias)
09/2013
1
Autistic Disorder (Autism)
11/2011
1
Timothy syndrome
11/2011
1
Obesity
11/2009
1
Overweight
11/2009
Drug/Important Bio-Agent (IBA)
2
Orexins
IBA
10/2022 - 11/2016
2
Messenger RNA (mRNA)
IBA
04/2014 - 09/2009
1
Orexin Receptor Antagonists
IBA
10/2022
1
suvorexant
IBA
10/2022
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
10/2021
1
Glucocorticoids
IBA
10/2021
1
Agouti-Related Protein
IBA
10/2021
1
rotigotine
FDA Link
11/2019
1
Dopamine Agonists (Dopamine Agonist)
IBA
11/2019
1
Histamine H1 Antagonists
IBA
10/2017
1
Ataxin-3
IBA
11/2016
1
Modafinil (Provigil)
FDA Link
11/2016
1
succinyl-coenzyme A (succinyl-CoA)
IBA
04/2014
1
acetoacetic acid (acetoacetate)
IBA
04/2014
1
Coenzyme A (CoA)
IBA
04/2014
1
Enzymes
IBA
04/2014
1
Ketone Bodies
IBA
04/2014
1
Transferases
IBA
04/2014
1
Vitamin A (Retinol)
FDA Link
Generic
09/2013
1
tamibarotene
IBA
09/2013
1
Dopamine (Intropin)
FDA Link
Generic
11/2011
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
11/2011
1
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
IBA
11/2011
1
L-Type Calcium Channels (Dihydropyridine Receptor)
IBA
11/2011
1
Calmodulin (Calcium-Dependent Activator Protein)
IBA
09/2009
1
Proteins (Proteins, Gene)
FDA Link
09/2009
1
Protein Kinases (Protein Kinase)
IBA
09/2009
1
Phosphotransferases (Kinase)
IBA
09/2009
1
Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)
IBA
09/2009
1
Bezafibrate
IBA
10/2008
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
04/2006
1
geranylgeranylacetone (teprenone)
IBA
04/2006
Therapy/Procedure
1
Caloric Restriction
11/2009